Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Sell
31
XHS Quote, Financials, Valuation and Earnings
Last price:
$97.83
Seasonality move
:
1.84%
Day range:
$96.57 - $97.39
52-week range:
$86.13 - $103.50
Dividend yield:
0.36%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
727
Avg. volume:
9.6K
1-year change:
6.82%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
XHS
SPDR S&P Health Care Services ETF
|
-- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- |
|
CNCR
Range Cancer Therapeutics ETF
|
-- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- |
|
SURI
Simplify Propel Opportunities ETF
|
-- | -- | -- | -- | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
XHS
SPDR S&P Health Care Services ETF
|
$95.31 | -- | -- | -- | $0.08 | 0.36% | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
$60.22 | -- | -- | -- | $0.00 | 0% | -- |
|
CNCR
Range Cancer Therapeutics ETF
|
$10.53 | -- | -- | -- | $0.00 | 0% | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
$30.47 | -- | -- | -- | $1.17 | 3.85% | -- |
|
SURI
Simplify Propel Opportunities ETF
|
$16.55 | -- | -- | -- | $0.68 | 19.88% | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
$42.95 | -- | -- | -- | $0.15 | 1.58% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
XHS
SPDR S&P Health Care Services ETF
|
-- | 1.844 | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | 1.217 | -- | -- |
|
CNCR
Range Cancer Therapeutics ETF
|
-- | 1.328 | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | 1.265 | -- | -- |
|
SURI
Simplify Propel Opportunities ETF
|
-- | 1.850 | -- | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
-- | 0.852 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
XHS
SPDR S&P Health Care Services ETF
|
-- | -- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- | -- |
|
CNCR
Range Cancer Therapeutics ETF
|
-- | -- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- | -- |
|
SURI
Simplify Propel Opportunities ETF
|
-- | -- | -- | -- | -- | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
SPDR S&P Health Care Services ETF vs. Competitors
-
Which has Higher Returns XHS or BBP?
Virtus LifeSci Biotech Products ETF has a net margin of -- compared to SPDR S&P Health Care Services ETF's net margin of --. SPDR S&P Health Care Services ETF's return on equity of -- beat Virtus LifeSci Biotech Products ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHSSPDR S&P Health Care Services ETF-- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- -
What do Analysts Say About XHS or BBP?
SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Virtus LifeSci Biotech Products ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Services ETF has higher upside potential than Virtus LifeSci Biotech Products ETF, analysts believe SPDR S&P Health Care Services ETF is more attractive than Virtus LifeSci Biotech Products ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHSSPDR S&P Health Care Services ETF0 0 0 BBPVirtus LifeSci Biotech Products ETF0 0 0 -
Is XHS or BBP More Risky?
SPDR S&P Health Care Services ETF has a beta of 1.067, which suggesting that the stock is 6.681% more volatile than S&P 500. In comparison Virtus LifeSci Biotech Products ETF has a beta of 0.678, suggesting its less volatile than the S&P 500 by 32.175%.
-
Which is a Better Dividend Stock XHS or BBP?
SPDR S&P Health Care Services ETF has a quarterly dividend of $0.08 per share corresponding to a yield of 0.36%. Virtus LifeSci Biotech Products ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. Virtus LifeSci Biotech Products ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHS or BBP?
SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than Virtus LifeSci Biotech Products ETF quarterly revenues of --. SPDR S&P Health Care Services ETF's net income of -- is lower than Virtus LifeSci Biotech Products ETF's net income of --. Notably, SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while Virtus LifeSci Biotech Products ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Services ETF is -- versus -- for Virtus LifeSci Biotech Products ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHSSPDR S&P Health Care Services ETF-- -- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- --
-
Which has Higher Returns XHS or CNCR?
Range Cancer Therapeutics ETF has a net margin of -- compared to SPDR S&P Health Care Services ETF's net margin of --. SPDR S&P Health Care Services ETF's return on equity of -- beat Range Cancer Therapeutics ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHSSPDR S&P Health Care Services ETF-- -- -- CNCRRange Cancer Therapeutics ETF-- -- -- -
What do Analysts Say About XHS or CNCR?
SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Range Cancer Therapeutics ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Services ETF has higher upside potential than Range Cancer Therapeutics ETF, analysts believe SPDR S&P Health Care Services ETF is more attractive than Range Cancer Therapeutics ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHSSPDR S&P Health Care Services ETF0 0 0 CNCRRange Cancer Therapeutics ETF0 0 0 -
Is XHS or CNCR More Risky?
SPDR S&P Health Care Services ETF has a beta of 1.067, which suggesting that the stock is 6.681% more volatile than S&P 500. In comparison Range Cancer Therapeutics ETF has a beta of 1.003, suggesting its more volatile than the S&P 500 by 0.282%.
-
Which is a Better Dividend Stock XHS or CNCR?
SPDR S&P Health Care Services ETF has a quarterly dividend of $0.08 per share corresponding to a yield of 0.36%. Range Cancer Therapeutics ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. Range Cancer Therapeutics ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHS or CNCR?
SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than Range Cancer Therapeutics ETF quarterly revenues of --. SPDR S&P Health Care Services ETF's net income of -- is lower than Range Cancer Therapeutics ETF's net income of --. Notably, SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while Range Cancer Therapeutics ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Services ETF is -- versus -- for Range Cancer Therapeutics ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHSSPDR S&P Health Care Services ETF-- -- -- -- CNCRRange Cancer Therapeutics ETF-- -- -- --
-
Which has Higher Returns XHS or SBIO?
ALPS Medical Breakthroughs ETF has a net margin of -- compared to SPDR S&P Health Care Services ETF's net margin of --. SPDR S&P Health Care Services ETF's return on equity of -- beat ALPS Medical Breakthroughs ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHSSPDR S&P Health Care Services ETF-- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- -
What do Analysts Say About XHS or SBIO?
SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ALPS Medical Breakthroughs ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Services ETF has higher upside potential than ALPS Medical Breakthroughs ETF, analysts believe SPDR S&P Health Care Services ETF is more attractive than ALPS Medical Breakthroughs ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHSSPDR S&P Health Care Services ETF0 0 0 SBIOALPS Medical Breakthroughs ETF0 0 0 -
Is XHS or SBIO More Risky?
SPDR S&P Health Care Services ETF has a beta of 1.067, which suggesting that the stock is 6.681% more volatile than S&P 500. In comparison ALPS Medical Breakthroughs ETF has a beta of 0.934, suggesting its less volatile than the S&P 500 by 6.615%.
-
Which is a Better Dividend Stock XHS or SBIO?
SPDR S&P Health Care Services ETF has a quarterly dividend of $0.08 per share corresponding to a yield of 0.36%. ALPS Medical Breakthroughs ETF offers a yield of 3.85% to investors and pays a quarterly dividend of $1.17 per share. SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. ALPS Medical Breakthroughs ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHS or SBIO?
SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than ALPS Medical Breakthroughs ETF quarterly revenues of --. SPDR S&P Health Care Services ETF's net income of -- is lower than ALPS Medical Breakthroughs ETF's net income of --. Notably, SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while ALPS Medical Breakthroughs ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Services ETF is -- versus -- for ALPS Medical Breakthroughs ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHSSPDR S&P Health Care Services ETF-- -- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- --
-
Which has Higher Returns XHS or SURI?
Simplify Propel Opportunities ETF has a net margin of -- compared to SPDR S&P Health Care Services ETF's net margin of --. SPDR S&P Health Care Services ETF's return on equity of -- beat Simplify Propel Opportunities ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHSSPDR S&P Health Care Services ETF-- -- -- SURISimplify Propel Opportunities ETF-- -- -- -
What do Analysts Say About XHS or SURI?
SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Simplify Propel Opportunities ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Services ETF has higher upside potential than Simplify Propel Opportunities ETF, analysts believe SPDR S&P Health Care Services ETF is more attractive than Simplify Propel Opportunities ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHSSPDR S&P Health Care Services ETF0 0 0 SURISimplify Propel Opportunities ETF0 0 0 -
Is XHS or SURI More Risky?
SPDR S&P Health Care Services ETF has a beta of 1.067, which suggesting that the stock is 6.681% more volatile than S&P 500. In comparison Simplify Propel Opportunities ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock XHS or SURI?
SPDR S&P Health Care Services ETF has a quarterly dividend of $0.08 per share corresponding to a yield of 0.36%. Simplify Propel Opportunities ETF offers a yield of 19.88% to investors and pays a quarterly dividend of $0.68 per share. SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. Simplify Propel Opportunities ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHS or SURI?
SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than Simplify Propel Opportunities ETF quarterly revenues of --. SPDR S&P Health Care Services ETF's net income of -- is lower than Simplify Propel Opportunities ETF's net income of --. Notably, SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while Simplify Propel Opportunities ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Services ETF is -- versus -- for Simplify Propel Opportunities ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHSSPDR S&P Health Care Services ETF-- -- -- -- SURISimplify Propel Opportunities ETF-- -- -- --
-
Which has Higher Returns XHS or XPH?
SPDR S&P Pharmaceuticals ETF has a net margin of -- compared to SPDR S&P Health Care Services ETF's net margin of --. SPDR S&P Health Care Services ETF's return on equity of -- beat SPDR S&P Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHSSPDR S&P Health Care Services ETF-- -- -- XPHSPDR S&P Pharmaceuticals ETF-- -- -- -
What do Analysts Say About XHS or XPH?
SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Services ETF has higher upside potential than SPDR S&P Pharmaceuticals ETF, analysts believe SPDR S&P Health Care Services ETF is more attractive than SPDR S&P Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHSSPDR S&P Health Care Services ETF0 0 0 XPHSPDR S&P Pharmaceuticals ETF0 0 0 -
Is XHS or XPH More Risky?
SPDR S&P Health Care Services ETF has a beta of 1.067, which suggesting that the stock is 6.681% more volatile than S&P 500. In comparison SPDR S&P Pharmaceuticals ETF has a beta of 0.747, suggesting its less volatile than the S&P 500 by 25.271%.
-
Which is a Better Dividend Stock XHS or XPH?
SPDR S&P Health Care Services ETF has a quarterly dividend of $0.08 per share corresponding to a yield of 0.36%. SPDR S&P Pharmaceuticals ETF offers a yield of 1.58% to investors and pays a quarterly dividend of $0.15 per share. SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. SPDR S&P Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHS or XPH?
SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than SPDR S&P Pharmaceuticals ETF quarterly revenues of --. SPDR S&P Health Care Services ETF's net income of -- is lower than SPDR S&P Pharmaceuticals ETF's net income of --. Notably, SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while SPDR S&P Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Services ETF is -- versus -- for SPDR S&P Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHSSPDR S&P Health Care Services ETF-- -- -- -- XPHSPDR S&P Pharmaceuticals ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
52
RGC alert for Mar 19
Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.
Sell
49
SRPT alert for Mar 19
Sarepta Therapeutics [SRPT] is up 8.72% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is up 5.74% over the past day.
